Douglas Lorne Arnold

43PUBLICATIONS
120CO-AUTHORS
Rural community developmentNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Optical technologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 22, 2026
A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.

|Feb 04, 2026
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.

Sezgi Kaçar, David R van Nederpelt, Julia R Jelgerhuis

|Dec 27, 2025
Periventricular gradients in axonal and myelin microstructure are present in people with multiple sclerosis having low and high disability.

Hannah R Bernstein, Vladimir Grouza, Joseph S Gati

|Dec 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial.

Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung

|Nov 05, 2025
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.

Krzysztof W Selmaj, Lawrence Steinman, Giancarlo Comi

|Aug 20, 2025
AI-driven reclassification of multiple sclerosis progression.

Habib Ganjgahi, Dieter A Häring, Piet Aarden

Pageof 8

Frequent Collaborators

11 joint publications

Ludwig Kappos

6 joint publications

Colm Elliott

5 joint publications

Giulia Fadda

5 joint publications

Bruce Ac Cree